Population pharmacokinetics (PK) of riociguat in patients (pts) with renal and hepatic impairment

被引：0
|
作者：
Saleh, Soundos
Becker, Corina
Frey, Reiner
Mueck, Wolfgang
机构：
来源：
EUROPEAN RESPIRATORY JOURNAL | 2014年 / 44卷
关键词：
Pulmonary hypertension;
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
P2354
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Effect of Renal or Hepatic Impairment on the Pharmacokinetics of Mirabegron
    James Dickinson
    Michaelene Lewand
    Taiji Sawamoto
    Walter Krauwinkel
    Marloes Schaddelee
    James Keirns
    Virginie Kerbusch
    Selina Moy
    John Meijer
    Donna Kowalski
    Richard Morton
    Kenneth Lasseter
    Dennis Riff
    Viera Kupčová
    Marcel van Gelderen
    Clinical Drug Investigation, 2013, 33 : 11 - 23
  • [22] Influence of Renal or Hepatic Impairment on the Pharmacokinetics of Saxagliptin
    David Boulton
    Li Li
    Ernst U. Frevert
    Angela Tang
    Lorna Castaneda
    Nimish N. Vachharajani
    David M. Kornhauser
    Chirag G. Patel
    Clinical Pharmacokinetics, 2011, 50 : 253 - 265
  • [23] Effects of hepatic or renal impairment on the pharmacokinetics of aripiprazole
    Mallikaarjun, Suresh
    Shoaf, Susan E.
    Boulton, David W.
    Bramer, Steven L.
    CLINICAL PHARMACOKINETICS, 2008, 47 (08) : 533 - 542
  • [24] Influence of Renal or Hepatic Impairment on the Pharmacokinetics of Saxagliptin
    Boulton, David W.
    Li, Li
    Frevert, Ernst U.
    Tang, Angela
    Castaneda, Lorna
    Vachharajani, Nimish N.
    Kornhauser, David M.
    Patel, Chirag G.
    CLINICAL PHARMACOKINETICS, 2011, 50 (04) : 253 - 265
  • [25] Effect of Hepatic or Renal Impairment on Eltrombopag Pharmacokinetics
    Bauman, John W.
    Vincent, Carolyn T.
    Peng, Bin
    Wire, Mary B.
    Williams, Daphne D.
    Park, Jung Wook
    JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 51 (05): : 739 - 750
  • [26] Effect of Renal or Hepatic Impairment on the Pharmacokinetics of Mirabegron
    Dickinson, James
    Lewand, Michaelene
    Sawamoto, Taiji
    Krauwinkel, Walter
    Schaddelee, Marloes
    Keirns, James
    Kerbusch, Virginie
    Moy, Selina
    Meijer, John
    Kowalski, Donna
    Morton, Richard
    Lasseter, Kenneth
    Riff, Dennis
    Kupcova, Viera
    van Gelderen, Marcel
    CLINICAL DRUG INVESTIGATION, 2013, 33 (01) : 11 - 23
  • [27] Effect of hepatic or renal impairment on the pharmacokinetics of evacetrapib
    David S. Small
    Wei Zhang
    Jane Royalty
    Ellen A. Cannady
    Delyn Downs
    Demetrio Ortega
    Jeffrey G. Suico
    European Journal of Clinical Pharmacology, 2016, 72 : 563 - 572
  • [28] Pharmacokinetics of Vandetanib in Subjects with Renal or Hepatic Impairment
    Angelika Weil
    Paul Martin
    Robert Smith
    Stuart Oliver
    Peter Langmuir
    Jessica Read
    Karl-Heinz Molz
    Clinical Pharmacokinetics, 2010, 49 : 607 - 618
  • [29] Pharmacokinetics of Tedizolid in Subjects with Renal or Hepatic Impairment
    Flanagan, S.
    Minassian, S. L.
    Morris, D.
    Ponnuraj, R.
    Marbury, T. C.
    Alcorn, H. W.
    Fang, E.
    Prokocimer, P.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (11) : 6471 - 6476
  • [30] Effect of hepatic or renal impairment on the pharmacokinetics of evacetrapib
    Small, David S.
    Zhang, Wei
    Royalty, Jane
    Cannady, Ellen A.
    Downs, Delyn
    Ortega, Demetrio
    Suico, Jeffrey G.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 72 (05) : 563 - 572
12345